New strategies for treatment of infectious diseases
Pathogens can directly damage the host tissues. The immune system of the host reduces the pathogen burden (amount of pathogens in the host) through resistance mechanisms. The immune response can also damage the host tissues. The host can reduce costs through tolerance mechanisms that reduce both the direct damage by pathogens and immunopathology (the negative impact of immune system defenses). Credit: Science/AAAS
The immune system protects from infections by detecting and eliminating invading pathogens. These two strategies form the basis of conventional clinical approaches in the fight against infectious diseases. In the latest issue of the journal Science, Miguel Soares from the Instituto Gulbenkian de Ciência (Portugal) together with Ruslan Medzhitov from Yale University School of Medicine and David Schneider from Stanford University propose that a third strategy needs to be considered: tolerance to infection, whereby the infected host protects itself from infection by reducing tissue damage and other negative effects caused by the pathogen or the immune response against the invader. The authors argue that identifying the mechanisms underlying this largely overlooked phenomenon may pave the way to new strategies to treat many human infectious diseases.
Upon invasion by pathogens (bacteria, viruses or parasites), the immune system kicks into action, by detecting, destroying and ultimately eliminating the pathogen. This so-called "resistance to infection" is crucial in protecting the host from infection, but is often accompanied by collateral damage to some of the host's vital tissues (liver, kidney, heart, brain). If uncontrolled tissue damage may have lethal consequences, as often happens, for example, in severe malaria, severe sepsis and possibly other infectious diseases. Tolerance reduces the harmful impact of infection and of the ensuing immune response on the host.
Although a well-studied phenomenon in plant immunity, tolerance to infection has been largely overlooked in mammals, including humans. While there is still much to be learnt about how and under which circumstances tolerance to infection is employed by the host, most of what is currently known about the molecular mechanisms underlying this host defense strategy comes from work carried out at the Instituto Gulbenkian de Ciência by the group led by Miguel Soares. The team is particularly interested in identifying disease-specific tolerance mechanisms, on the one hand, and also general strategies of tolerance, that may, possibly, be employed protectively, to precondition the host to future infections.
Because resistance is, generally, the only mechanism considered in animal and human studies, when the host capitulates to infection it is often attributed to failure of the immune system. The authors argue that this is not always the case, and underscore the importance of distinguishing between failed resistance and failed tolerance as the cause for morbidity and mortality by infectious diseases. This distinction will dictate the choice of therapeutic approaches. When the primary problem is failed tolerance, then boosting the immune system, or administering antibiotics, may be ineffective. In this case, enhancing tolerance would possibly be much more effective in fighting infectious, inflammatory and auto-immune diseases.
Provided by Instituto Gulbenkian de Ciencia
- Flu-induced stress response is critical for resistance to secondary infection Feb 17, 2010 | not rated yet | 0
- Study helps explain how pathogenic E. coli bacterium causes illness Mar 14, 2011 | not rated yet | 0
- Naturally occurring protection against severe malaria Aug 17, 2009 | not rated yet | 0
- DNA of good bacteria drives intestinal response to infection Oct 02, 2008 | not rated yet | 0
- Research confirms novel strategy in fight against infectious diseases Jan 09, 2012 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
The Durability of Bone: Long Falls
1 hour ago I am doing a paper on the physics in Valve's Portal and got interested in the "Long Fall Boots" that prevent any damage no matter how far you fall. I...
Is energy convertible to matter?
2 hours ago Can we convert energy to matter?
Rotating electron as a dipole is this right?
5 hours ago An electron as shown by the Stern Gerlach experiment behaves like a dipole (albeit only in one of two states). I have been trying to figure out how...
Dipole term in multipole expansion
9 hours ago Hi. I'm having some difficult in understanding something about the dipole term in a multipole expansion. Griffiths writes the expansion as a sum of...
Bubbles in a Pre-Boiling/Boiling pot of water
10 hours ago How is it that bubbles form on the bottom of a surface of a pot of boiling water? I think that there is probably an elementary answer to this...
Assumptions of Griffith's fracture theory
20 hours ago Any experts on Griffith's fracture theory? I am studying the subject and I am having hard time finding out if the theory is valid for all possible...
- More from Physics Forums - Classical Physics
More news stories
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Immunology May 20, 2013 | 4.8 / 5 (21) | 8 |
(Medical Xpress)—Scientists at King's College London have discovered that Vitamin D has the potential to significantly reduce the symptoms of asthma. The study, led by Professor Catherine Hawrylowicz from ...
Immunology May 20, 2013 | 5 / 5 (1) | 0 |
Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been destroyed.
Immunology May 20, 2013 | 5 / 5 (5) | 0 |
Raising hopes for cell-based therapies, UC San Francisco researchers have created the first functioning human thymus tissue from embryonic stem cells in the laboratory. The researchers showed that, in mice, ...
Immunology May 16, 2013 | 4.8 / 5 (5) | 0 |
Researchers from CNRS, Université Toulouse III - Paul Sabatier and IRD have elucidated new molecular mechanisms involved in resistance to visceral leishmaniasis, a serious parasitic infection. They have shown that dectin-1 ...
Immunology May 16, 2013 | not rated yet | 0
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
11 hours ago | 4.2 / 5 (5) | 0 |
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
9 hours ago | 4.9 / 5 (8) | 0 |
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
5 hours ago | 3 / 5 (2) | 0
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
5 hours ago | 5 / 5 (3) | 0 |
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
11 hours ago | 4.4 / 5 (5) | 0 |
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
6 hours ago | not rated yet | 0 |